CRANBURY, N.J., May 8 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. will announce its third quarter, fiscal year 2008 financial results for the period ended March 31, 2008 before the open of the U.S. financial markets on May 13, 2008.
The Company will also conduct a teleconference and live audio webcast hosted by Palatin’s executive management team on May 13, 2008 at which they will discuss the results of operations in greater detail and provide an update on corporate developments.
About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics. The Company’s internal research and development capabilities, anchored by its proprietary MIDAS(TM) technology, are fueling product development. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. The Company currently has collaborations with AstraZeneca and the Mallinckrodt division of Covidien. For additional information regarding Palatin, please visit Palatin Technologies’ website at http://www.palatin.com.
CONTACT: Stephen T. Wills, CPA, MST, EVP-Operations - Chief Financial
Officer of Palatin Technologies, Inc., +1-609-495-2200, info@palatin.com;
or Institutional Investors and Media, Carney Noensie of Burns McClellan,
+1-212-213-0006, cnoensie@burnsmc.com
Web site: http://www.palatin.com/
